Give us a Call
+1 (915) 412-6680
Send us a Message
[email protected]
Opening Hours
Mon-Thu: 7 AM - 7 PM
Fri - Sun: Closed

Regenerative Medicine Best Practices for Patient Optimization

Understand the importance of patient optimization in regenerative medicine and its role in modern healthcare advancements.

Abstract

Hello, I’m Dr. Alex Jimenez. With my extensive background in integrative and functional medicine, holding titles including DC, APRN, FNP-BC, CFMP, IFMCP, ATN, and CCST, I’ve dedicated my career to optimizing patient health from every angle. In this educational post, we will journey through the critical yet often overlooked phase of preparing the body for orthobiologic and regenerative therapies. I believe that optimizing the patient’s internal environment—their personal “pharmacy”—is just as crucial as the biologic treatment itself. We will explore the six pillars of lifestyle medicine: diet, exercise, sleep, stress mitigation, social connectedness, and the avoidance of risky substances. Drawing on the latest evidence-based research, we’ll discuss how conditions such as obesity, chronic low-grade inflammation, sarcopenia, and gut dysbiosis can significantly affect the success of regenerative procedures. I will provide a comprehensive framework for assessing and enhancing a patient’s metabolic health, including specific dietary recommendations, exercise protocols, and screening tools. We will also delve into how integrative chiropractic care complements this process by addressing the biomechanical and neurological factors that influence healing, ensuring a truly holistic approach to recovery and long-term wellness.

The Foundation of Healing: Why Patient Optimization is Non-Negotiable

As a practitioner deeply invested in both chiropractic and functional medicine, my perspective is uniquely shaped by a diverse background that includes public health and a passion for holistic wellness. When a patient comes to me for an orthobiologic procedure, my focus isn’t just on the treatment itself. It extends to a fundamental question: Is this patient’s body prepared to heal? I am passionate about making sure every patient is as metabolically optimized as possible before we proceed.

Think of it this way: the biologics we use, whether platelet-rich plasma (PRP) or cellular therapies, are catalysts. But the real work of healing happens within the patient’s own body. We are, in essence, optimizing their internal pharmacy. By improving their metabolic health, we are ensuring that the “raw materials” for regeneration are abundant and that the environment is conducive to repair rather than breakdown. This concept is the cornerstone of my practice and is supported by a growing body of research highlighting the profound connection between lifestyle and regenerative potential.

The Six Pillars of Lifestyle Medicine in Regenerative Care

To structure this optimization process, I use the framework of lifestyle medicine. This evidence-based approach focuses on six key areas that collectively determine our overall health. When we improve these pillars, we achieve maximum metabolic optimization, creating the ideal conditions for regenerative treatments to succeed. While we have few, if any, large-scale randomized controlled trials (RCTs) directly linking these pillars to biologic outcomes, a wealth of data from other fields allows us to extrapolate and apply these principles with confidence. We know, for instance, that dietary interventions can improve platelet function and that exercise can enhance cellular activity (Paolucci et al., 2023).

Here are the six pillars we focus on:

  • Diet and Nutrition: Fueling the body for repair.
  • Physical Activity: Moving to enhance cellular function.
  • Restorative Sleep: The non-negotiable recovery phase.
  • Stress Management: Taming the silent saboteur of healing.
  • Social Connection: The powerful influence of community on health.
  • Avoidance of Risky Substances: Eliminating toxins that hinder regeneration.

Identifying and Addressing Key Barriers to Healing

A pivotal review article has identified six specific aspects of health that can significantly influence the outcomes of our procedures (Centeno et al., 2023). Our goal is to ensure that patients walk away from our care not just with temporary relief but with a profound, lasting improvement in their quality of life. By addressing these factors, we build a reputation for excellence.

These six critical aspects are:

  1. Obesity: Excess weight doesn’t just add mechanical stress to joints. For every pound of weight lost around the midsection, there’s a roughly four-fold decrease in the load on the knee joint. But beyond the mechanics, obesity is a state of metabolic dysregulation, characterized by adipokines—inflammatory molecules secreted by fat cells—that create a hostile environment for healing.
  2. Chronic Low-Grade Inflammation: This isn’t the acute, beneficial inflammation that initiates healing after an injury. This is a persistent, systemic inflammation that slowly degrades tissues and impairs regenerative processes.
  3. Sarcopenia: the age-related loss of muscle mass and function. Muscle is a metabolic powerhouse, and its decline compromises the body’s ability to heal and maintain stability.
  4. Gut Dysbiosis: This term describes an imbalance in your gut microbiota—the trillions of microorganisms living in your digestive tract. When these communities are out of balance, they can produce toxic byproducts that leak into the bloodstream, driving systemic inflammation and disrupting immune function.
  5. Sleep Deprivation: Anyone with a child understands how crucial sleep is. Lack of sleep dysregulates key hormones like cortisol, impairs immune function, and heightens pain sensitivity.
  6. Unhealthy Lifestyle Behaviors: A patient might be a marathon runner, but if they are also smoking heavily, the toxic exposure will negate many of the benefits. We must look at the patient’s life in its entirety.

Fueling Regeneration: The Power of an Anti-Inflammatory Diet

Your diet is one of the most powerful tools for influencing your body’s internal environment. We know that conditions like obesity and insulin resistance are detrimental, leading to impaired cellular function and a reduced capacity for healing. This is because high blood sugar and insulin levels create a pro-inflammatory state hostile to the very regeneration we aim to stimulate.

The gut-body connection is another critical piece of the puzzle. An imbalanced gut microbiome, or gut dysbiosis, can directly contribute to systemic inflammation, sabotaging our efforts. I believe we are only scratching the surface of how the gut impacts musculoskeletal health, and future research will undoubtedly reinforce this link.

Proposed Dietary Approach

My recommendation for patients is to adopt an anti-inflammatory diet. This isn’t a fad; it’s a dietary pattern that has been used successfully for years in rheumatology to manage inflammatory arthritis. The principles are simple and effective:

  • Increase Fiber and Leafy Greens: These feed beneficial gut bacteria and are rich in phytonutrients that help combat inflammation.
  • Boost Omega-3 Fatty Acids: Found in fatty fish, flaxseeds, and walnuts, these fats are precursors to powerful anti-inflammatory molecules.
  • Focus on Low-Glycemic-Index Foods: Choose whole grains, legumes, and non-starchy vegetables to help stabilize blood sugar and insulin levels.
  • Ensure Adequate Protein Intake: Protein provides the essential amino acids needed for tissue repair and collagen synthesis.
  • Avoid Processed Foods and Refined Sugars: These are primary drivers of inflammation and metabolic dysfunction.

Do We Need Supplements?

For a patient eating a varied, whole-foods diet, supplementation is often unnecessary. However, if there are concerns about nutritional gaps, certain nutrients can be particularly helpful:

  • Vitamin C: Essential for collagen synthesis, the primary protein in our connective tissues.
  • Vitamin D & Magnesium: Crucial for muscle function, bone health, and immune regulation.
  • Zinc & Copper: These minerals are cofactors in numerous enzymatic reactions vital for tissue repair.
  • Probiotics: Can help restore balance to the gut microbiome, potentially reducing systemic inflammation.

It’s important to note that the evidence regarding supplementation in relation to orthobiologic procedures is mixed. Some studies may suggest discontinuing certain supplements before a procedure, so it is always best to work with a knowledgeable provider to create a personalized plan.

Movement as Medicine: Exercise Protocols for Enhanced Healing

Exercise is a potent medicine that positively impacts every barrier to healing we’ve discussed. It combats obesity and insulin resistance, lowers chronic inflammation, improves sleep quality, and reverses sarcopenia.

From an orthobiologic perspective, the benefits are even more direct:

  • Optimize Cellular Quality: Exercise can increase platelet counts and even enhance growth factor concentrations within platelets.
  • Improve Tissue Responsiveness: Regular physical activity makes your tissues more receptive to the growth signals initiated by regenerative treatments.
  • Limit Cellular Senescence: Exercise helps clear out old, dysfunctional “zombie” cells and improves the function, replication, and differentiation capacity of your own mesenchymal stem cells (MSCs).

Exercise Recommendations

As part of my intake, I use what’s called an “exercise vital sign,” a quick two-question screen to gauge a patient’s activity level. The goal is to meet or exceed the following recommendations:

  • Aerobic Exercise: At least 150 minutes per week of moderate-intensity activity (e.g., brisk walking, cycling). I often tell my patients that while this is the ideal, any movement toward this goal is a step in the right direction.
  • High-Intensity Interval Training (HIIT): Incorporating short bursts of intense effort followed by recovery periods is particularly effective at improving endothelial function—the health of your blood vessel lining—which is critical for delivering nutrients and healing factors to tissues.
  • Resistance Training: Aim for at least two sessions per week. Building and maintaining muscle is metabolically protective and provides crucial support for our joints.
  • Pre-Procedure Exercise: Intriguing research suggests that an acute bout of high-intensity exercise immediately before a PRP blood draw can temporarily increase circulating platelet levels (Liao et al., 2021). This is a simple strategy I often incorporate, having patients perform a short workout at a nearby gym just before their appointment.

The Healing Diet: Combat Inflammation, Embrace Wellness- Video

The Critical Role of Restorative Sleep

Sleep is when the body’s most important repair processes occur. The standard recommendation of seven to nine hours per night is not arbitrary; it’s a biological necessity. Inadequate sleep disrupts the delicate balance of our endocrine system, particularly affecting cortisol regulation. While often vilified, cortisol plays a vital role in managing inflammation, but chronically elevated levels due to poor sleep suppress the very pro-inflammatory signals needed to kickstart healing.

Furthermore, poor sleep significantly impacts central pain modulation. A sleep-deprived patient will perceive more pain from the procedure and during recovery. In my clinical observations at our clinics, patients who prioritize sleep hygiene consistently report better pain control and smoother recoveries. Special attention should be paid to conditions like obstructive sleep apnea (OSA), which can cause endothelial dysfunction due to intermittent hypoxia (low oxygen levels). I routinely screen for OSA, and it’s not uncommon for this screening to lead to a new diagnosis and life-changing treatment for a patient.

Eliminating Toxic Burdens: Tobacco and Alcohol

I am very direct with my patients about this: tobacco and alcohol are Group 1 carcinogens, meaning they are definitively known to cause cancer. Their negative impact on healing is just as definitive.

  • Tobacco: Nicotine is directly cytotoxic to MSCs (your stem cells) and causes abnormal platelet aggregation. It constricts blood vessels, starving tissues of the oxygen and nutrients they desperately need to heal.
  • Alcohol: Extensive surgical data shows that alcohol consumption increases the risk of post-procedure infection and impairs wound healing. It also directly damages MSCs and depletes key nutrients.

My approach is to counsel patients frankly about these risks and connect them with resources such as quit lines, pharmacotherapy, or a referral back to their primary care provider to develop a cessation strategy. A regenerative procedure is a significant investment of time, money, and hope—it makes no sense to undermine it with toxic exposures.

The Biopsychosocial Model: Stress, Social Connection, and Pain

The mind-body connection is not a new-age concept; it is a biological reality. Chronic stress leads to elevated cortisol levels, which, as we’ve discussed, impair tissue healing, suppress beneficial inflammation, and restrict the proliferation and differentiation of MSCs.

Conversely, strong social connections and effective stress management techniques are powerful buffers. Much of the data in this area revolves around pain mitigation. Patients who feel supported, understood, and emotionally resilient experience less pain and have better functional outcomes. This is why I advocate for a biopsychosocial evaluation, where we assess for stress, anxiety, and depression. It is crucial, however, that if you screen for these conditions, you must have the resources in place to provide or refer for appropriate support, such as behavioral health counseling. You can’t just ask the question and leave the patient hanging.

The Role of Integrative Chiropractic Care

This is where the principles of integrative chiropractic care fit seamlessly into the patient optimization plan. While functional medicine addresses the body’s biochemistry, chiropractic care focuses on its biomechanics and neurology. The two are inextricably linked.

  • Restoring Biomechanical Function: A misaligned joint or dysfunctional movement pattern places abnormal stress on tissues. This chronic mechanical strain can perpetuate inflammation and create a “stuck” point that resists healing, even with biologics. Through precise spinal and extremity adjustments, we restore proper joint mechanics, unload compromised tissues, and create a better environment for regenerative cells to work.
  • Improving Neurological Input: Chiropractic adjustments have a profound effect on the nervous system. By stimulating mechanoreceptors in the joints and soft tissues, we can downregulate pain signals (nociception) and improve proprioception (the body’s sense of its position in space). This helps break the chronic pain cycles that often accompany degenerative conditions and can improve a patient’s tolerance for rehabilitative exercise.
  • Enhancing Blood Flow and Fluid Dynamics: Proper movement is essential for pumping blood and lymphatic fluid, which deliver nutrients and remove waste products. Chiropractic care, combined with soft-tissue modalities, helps release restrictions and improve circulation in the target area, ensuring that regenerative therapies are delivered where they are needed most.

By integrating chiropractic adjustments, we are not just treating the site of injury; we are optimizing the entire kinetic chain and the neurological signaling that governs it. This ensures the patient’s body is mechanically and neurologically receptive to healing.

A Practical Approach to Pre-Procedure Assessment

So, how do we put all this into practice? It starts with a thorough assessment. If a patient’s recent medical records (within the last six months) are available and appear to be in good condition, extensive new testing may not be needed. However, I typically start with some simple point-of-care measurements.

Initial Screening:

  • Vitals: Height, weight, blood pressure, and waist circumference (a key indicator for metabolic syndrome).
  • Point-of-Care Labs: A fasting glucose and a lipid panel can quickly identify or rule out metabolic syndrome. Key markers are triglycerides and HDL cholesterol.
  • Further Labs (if indicated): Based on the initial screen and patient history, I might order a Hemoglobin A1c (to assess long-term blood sugar control), C-Reactive Protein (CRP, a marker of inflammation), or a renal function panel.

Screening Questionnaires:

Validated questionnaires are an efficient way to gather crucial information:

  • Lifestyle: Simple screens for tobacco/alcohol use, exercise, and diet.
  • Sleep: Questionnaires like the STOP-BANG can screen for sleep apnea risk.
  • Mental Health: Tools to assess for stress, anxiety, and depression (e.g., PHQ-9, GAD-7).

Creating an Optimization Plan

Based on this comprehensive assessment, I classify a patient’s metabolic risk as low, moderate, or high.

  • Low Risk: A patient with no signs of metabolic syndrome.
  • High Risk: A patient presenting with, for example, a Hemoglobin A1c of 11% and uncontrolled hypertension.

For a patient with moderate-to-high metabolic risk who is otherwise a good candidate for a biologic procedure (e.g., rotator cuff tendinopathy), this is the perfect opportunity to intervene. I present them with the information, we establish baseline markers, and we collaboratively set a timeline—often 8 to 12 weeks—to focus on optimization. We then repeat the key markers to track progress. This process of shared decision-making empowers the patient and dramatically increases their chances of a successful outcome.

The optimization “prescription” might include:

  • Specific Exercise Goals: “You need to achieve 150 minutes of brisk walking per week.”
  • Dietary Counseling: Providing clear guidelines or referring to a registered dietitian.
  • Sleep Hygiene Strategies.
  • Stress Mitigation Techniques: Recommending mindfulness apps, deep breathing exercises, or a referral for counseling.
  • Cessation Support: For tobacco and alcohol use.

This pre-habilitation period is an investment that pays dividends long after the procedure, fostering lifestyle changes that promote lifelong health. Thank you for joining me on this exploration of patient optimization.


References


SEO Tags: regenerative medicine, orthobiologics, patient optimization, lifestyle medicine, integrative chiropractic, platelet-rich plasma, PRP, stem cell therapy, metabolic health, anti-inflammatory diet, gut dysbiosis, sarcopenia, chronic inflammation, exercise physiology, sleep hygiene, stress management, functional medicine, Dr. Alex Jimenez, chiropractic care, holistic healing

Cardiometabolic Health Solutions With GLP-1 Therapy

Discover the impact of GLP-1 therapy on cardiometabolic health and how it can benefit individuals seeking better wellness.

Abstract: A New Paradigm in Metabolic Health

Welcome to our educational post on the revolutionary class of medications known as GLP-1 receptor agonists. As a practitioner deeply rooted in integrative and functional medicine, with a diverse background spanning chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP), my primary goal has always been to find the most effective, evidence-based strategies to improve my patients’ health. My clinical observations at our El Paso and San Antonio clinics, coupled with the latest research, continually point toward a more integrated and holistic approach to chronic disease. This post will serve as your guide, translating complex clinical trials and physiological mechanisms into an easy-to-understand narrative. We will delve into how these powerful agents work, explore the landmark cardiovascular outcomes trials (CVOTs) that revealed their ability to protect the heart and kidneys, and differentiate among the available options, such as semaglutide (Ozempic/Wegovy) and the dual-agonist tirzepatide (Mounjaro/Zepbound). Furthermore, we will delve into the practical aspects of using these therapies, including managing side effects, understanding safety considerations, and exploring their investigational uses in everything from neuroprotection to fertility. Most importantly, we’ll connect these pharmacological advancements back to the core principles of integrative health, examining how integrative chiropractic care is essential for maximizing patient outcomes and achieving true, sustainable well-being.

Rethinking Diabetes: Beyond Glucose-Centric Care

In my years of practice, I’ve seen firsthand the devastating impact of diabetes on my patients’ lives. For decades, the management of type 2 diabetes was primarily focused on lowering blood glucose levels. However, we now understand that this is only one piece of a much larger puzzle. It’s a reality underscored by stark statistics. We know that atherosclerotic cardiovascular disease (ASCVD)—which encompasses coronary heart disease, stroke, and peripheral arterial disease—is the leading cause of death for individuals with type 2 diabetes. In fact, more than 70% of elderly patients with diabetes will likely succumb to heart disease or a stroke. The prognosis following a heart attack is significantly poorer for someone with diabetes compared to someone without, and alarmingly, these outcomes often remain bleak even when blood glucose levels are considered “well-controlled.”
This has forced a critical shift in our clinical strategy. The old model, which I call the “glucose-centric” approach, is no longer sufficient. We must move toward a multifaceted management plan that reduces overall risk. This requires a collaborative and integrative effort.

Pillars of Modern Diabetes Management

The world’s leading medical bodies, including the American College of Cardiology (ACC), the American Heart Association (AHA), the American Diabetes Association (ADA), and the Kidney Disease Improving Global Outcomes (KDIGO) group, are all aligned on this new, comprehensive approach. It’s no longer just about the A1c. Our focus must be on:
Lifestyle Management: Foundational changes in diet and physical activity.
Diabetes Self-Management Education: Empowering patients with the knowledge to control their condition.
Cardiovascular Risk Reduction: Aggressively managing blood pressure, cholesterol (lipids), and, of course, glucose levels.
Weight Management: Addressing excess weight as a key driver of metabolic dysfunction.
Smoking Cessation: Eliminating a major accelerator of cardiovascular disease.
This holistic view is the cornerstone of effective, 21st-century care.

Clinical Case Study: The Challenge of “Over-Basalization”

To illustrate these concepts, let’s consider a case similar to many patients I see in my clinic. We’ll call her Naomi.
Naomi is a 66-year-old female who has been living with type 2 diabetes for 12 years. Despite being on a robust medication regimen, her health is not where it needs to be.
A1c: Her last A1c was 8.3%, well above the target of less than 7%.
Comorbidities: She has high cholesterol (hyperlipidemia), hypertension, and protein in her urine (proteinuria), a sign of early kidney stress.
Medications:
Metformin 1000 mg twice daily.
Degludec insulin (a basal insulin): 66 units daily.
An SGLT-2 inhibitor (a class of oral diabetes medication).
A statin for cholesterol.
An ARB for blood pressure.
Weight: She weighs 220 pounds and is 5’9 “, giving her a BMI of 32.5, placing her in the obese category.
Glucose Readings:
Her fasting glucose levels are between 140 and 160 mg/dL. The goal is typically 90-130 mg/dL.
Her postprandial (after-meal) glucose levels are 160-170 mg/dL. While the ADA goal is under 180 mg/dL, many specialists, including myself, prefer to see this number much lower, ideally under 140 mg/dL two hours after a meal.

The Problem: Over-Basalized and Still Not at Goal

Naomi’s case highlights a common clinical problem: “over-basalization.” She is taking a very high dose of basal insulin, yet her A1c and fasting glucose are still too high. A simple clinical calculation I use is to multiply a patient’s weight in kilograms by 0.5. For Naomi, who weighs 100 kg, this suggests that a basal insulin dose above 50 units may be excessive. At 66 units, she is clearly over-basalized.
The high basal insulin dose isn’t effectively controlling her blood sugar, and it’s likely contributing to her difficulty with weight management. The logical next step in a traditional model might be to add prandial (mealtime) insulin to cover her post-meal glucose spikes. However, this is where we can intervene more intelligently. Before adding more insulin, which often leads to further weight gain and increased risk of hypoglycemia, we should consider a GLP-1 receptor agonist. This approach leverages the body’s natural “incretin effect” to address the very issue Naomi is struggling with: postprandial hyperglycemia.

Understanding GLP-1 Receptor Agonists: The Incretin Effect

To truly appreciate these medications and understand why a GLP-1 agent is such a powerful tool, we need to talk about the “incretin effect.” This term describes a fascinating physiological process that is glucose-dependent, meaning these hormones act primarily when glucose is present. Our bodies naturally produce incretin hormones, specifically GLP-1 (Glucagon-Like Peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), which are synthesized and released by specialized “L-cells” in the jejunum, a part of our small intestine.
This release is triggered by the presence of food in the gut. When you eat a meal, these hormones are secreted into the bloodstream, orchestrating a multi-pronged response:
Stimulates Insulin Secretion: It signals the pancreas to increase insulin secretion, but only in a glucose-dependent manner. This means it only works when blood sugar is high, dramatically reducing the risk of hypoglycemia compared to insulin or other medications.
Suppresses Glucagon Release: It signals the pancreas to stop releasing glucagon, a hormone that prompts the liver to produce more glucose. This prevents unnecessary glucose from entering the bloodstream.
Slows Gastric Emptying: It slows down the rate at which food leaves the stomach. This makes you feel full sooner and for longer, helping to control appetite and prevent sharp, rapid spikes in blood sugar after meals.
Promotes Satiety: It acts directly on the brain to reduce appetite and increase feelings of fullness.
In individuals with type 2 diabetes, this natural incretin effect is often blunted or, in some cases, completely absent. They produce very low levels of their native GLP-1 hormone. This deficiency leads to insufficient insulin secretion after meals and a failure to suppress glucagon. The result is the hallmark hyperglycemia we see in diabetes. GLP-1 receptor agonists are medications designed to mimic the action of our own GLP-1, but they are engineered to last much longer in the body, restoring and amplifying these beneficial effects.

Mechanisms of Action: More Than Just Blood Sugar Control

The mechanisms of these drugs are multifaceted and explain not only their benefits but also their common side effects.
Gastrointestinal System: In the presence of a GLP-1 agonist, gastric emptying is significantly slowed. This delay is a primary reason patients feel full for longer, which naturally leads to reduced food intake and contributes to weight loss. Unfortunately, this slowing effect can also cause side effects like mild nausea and occasionally vomiting, especially in individuals with a history of gastroparesis. Some patients may experience diarrhea, while others report constipation or mild abdominal pain.
Central Nervous System (Brain): We believe that these small-molecule drugs can cross the blood-brain barrier and act directly on the brain’s appetite centers, such as the hypothalamus. This central action helps to decrease appetite and reduce food cravings, providing another powerful mechanism for weight loss. The feeling of prolonged satiety is likely a combination of this central effect and the delayed gastric emptying.
Pancreas: In the pancreas, GLP-1 agonists stimulate glucose-dependent insulin secretion from the beta cells. Simultaneously, they suppress glucagon secretion. By lowering glucagon, they help reduce the liver’s inappropriate production and release of stored glucose, a common dysfunction in type 2 diabetes.

The “Ominous Octet” and the Power of GLP-1s

In 2009, the renowned endocrinologist Dr. Ralph DeFronzo published a seminal paper describing the “Ominous Octet”—eight core pathophysiological defects that contribute to type 2 diabetes (DeFronzo, 2009). This framework helps us understand the complexity of the disease. What is remarkable is that GLP-1 receptor agonists address six of these eight defects very effectively. Their widespread use makes them among the most comprehensive therapies available.

Choosing the Right GLP-1 Agonist: A Comparative Look

The family of GLP-1 agents has grown, offering us a variety of options with distinct profiles. It’s crucial to choose an agent that aligns with the individual patient’s needs. Let’s look at the data from leading researchers to understand the impact of these medications. When we compare these agents, we see a clear progression in efficacy:
Liraglutide resulted in a weight loss of about 2.7 kilograms and a just under 1% reduction in HbA1c.
Dulaglutide improved upon this, showing an average weight loss of 4.6 kilograms.
Semaglutide represented a significant leap forward, demonstrating an average weight loss of 6.4 kilograms and a more robust HbA1c reduction of between 1.8% and 2.1%.
Then came tirzepatide, a dual GIP and GLP-1 receptor agonist, which has shown truly remarkable results. In clinical trials, it was associated with an average weight loss of 11.2 kilograms—almost double that of semaglutide—and an impressive 2.3% reduction in HbA1c.
It’s crucial to note that these powerful results, particularly for weight loss, were observed at the higher doses approved by the FDA during the drug approval process. Here’s a breakdown of the key players, based on the latest research and FDA indications as of May 21, 2026:
Medication (Brand Name)
Key Indications & Benefits
A1c Lowering
Typical Weight Loss
Semaglutide (Ozempic/Rybelsus)
Type 2 Diabetes, Weight Loss (Wegovy), MACE Reduction, Nephropathy Protection. Semaglutide is a potent agent with robust evidence of cardiovascular and kidney benefits.
~1.5-2.0%
~15% of body weight
Tirzepatide (Mounjaro/Zepbound)
Type 2 Diabetes, Weight Loss, OSA. This is a “twincretin,” a dual GLP-1/GIP agonist, showing the highest efficacy for both glucose lowering and weight loss. Cardiovascular outcome trials are ongoing but look promising.
>2.0%
>20% of body weight
Dulaglutide (Trulicity)
Type 2 Diabetes, MACE Reduction, Nephropathy Protection. A reliable weekly injection with proven cardiovascular and kidney benefits, though with more moderate weight loss compared to newer agents.
~1.0-1.5%
~3-5 kg
Liraglutide (Victoza)
Type 2 Diabetes, MACE Reduction, Nephropathy Protection. One of the first GLP-1s with proven cardiovascular benefits, but it requires a daily injection. Weight loss is more modest. A higher dose is available for weight loss (Saxenda).
~1.1%
~2.5 kg
Exenatide (Byetta/Bydureon)
Type 2 Diabetes. One of the earliest GLP-1s. It is effective for glucose control but has less impact on weight and lacks the proven cardiovascular protection of newer agents.
<1.0%
~2.9 kg
MACE = Major Adverse Cardiovascular Events (heart attack, stroke, cardiovascular death). OSA = Obstructive Sleep Apnea.
 
 
 
When I select a GLP-1 agonist for a patient, I’m not just looking at the A1c. For Naomi, who has hypertension and proteinuria, choosing an agent with proven MACE reduction and nephropathy protection like semaglutide (Ozempic) or dulaglutide (Trulicity) would be a critical part of a comprehensive strategy. Given her significant need for weight loss and A1c reduction, semaglutide or tirzepatide would be the top consideration.

Cardiovascular Outcomes Trials (CVOTs): The Game-Changer

The history of diabetes medications is marked by a pivotal moment in 2008. Following safety concerns with earlier drugs, the FDA mandated that all new diabetes drugs undergo large, long-term Cardiovascular Outcomes Trials (CVOTs). The goal was to demonstrate that these new drugs did not harm the cardiovascular system.
What happened next was completely unexpected and revolutionized our field. Not only were these drugs safe, but they also provided robust cardiovascular risk reduction. This discovery shifted the paradigm from “just diabetes drugs” to essential tools for cardiologists and nephrologists. The GLP-1 receptor agonists soon followed with their own impressive CVOT data:
REWIND Trial (Dulaglutide): Showed a 12% reduction in major adverse cardiovascular events (MACE).
LEADER Trial (Liraglutide): Showed a 13% reduction in MACE.
SUSTAIN-6 Trial (Subcutaneous Semaglutide): Showed a remarkable 26% reduction in MACE.
These large, multi-year, double-blind, placebo-controlled studies involving thousands of patients solidified the role of these medications as cornerstones of cardio-renal-metabolic care. We now view metabolic disease through the lens of the cardio-renal-metabolic (CRM) triad. These systems are bidirectionally linked; a problem in one inevitably affects the others.

How Professional Guidelines Position GLP-1 Agonists

The American Diabetes Association (ADA) has recognized the profound benefits of these medications. The 2025 ADA guidelines, published annually in Diabetes Care, place a strong emphasis on GLP-1 receptor agonists, especially for certain patient populations (ElSayed et al., 2024).
The ADA treatment algorithm is divided into two main pathways:
The Left-Hand Pathway: For patients with established atherosclerotic cardiovascular disease (ASCVD), heart failure, or chronic kidney disease (CKD), or those at very high risk. For these patients, a GLP-1 receptor agonist is now strongly favored as a primary agent, sometimes even before metformin.
The Right-Hand Pathway: For patients whose primary needs are glycemic control and weight management but who do not have the high-risk cardiovascular or kidney profile.
For patients with CKD, SGLT2 inhibitors are often the first choice. However, certain GLP-1 agonists, specifically semaglutide, have also earned an indication for kidney protection. The FLOW trial, stopped early due to overwhelmingly positive results, demonstrated that semaglutide reduced the risk of major kidney disease events and cardiovascular death by 24% in people with type 2 diabetes and CKD.

Balancing Body and Metabolism- Video

Navigating the Switch: A Guide to Changing GLP-1 Agonists

As a clinician committed to patient-centered care, I often encounter scenarios in which a medication switch is considered. A recent case involved a patient, we’ll call her Tammy, who was on Trulicity (dulaglutide) but wasn’t achieving her desired weight loss. Through shared decision-making, we explored a switch. This requires a careful, evidence-informed approach.
Switching from Trulicity (dulaglutide) to Ozempic (semaglutide): To switch from a 1.5 mg dose of dulaglutide, I would begin her on semaglutide 0.5 mg weekly. This conservative start minimizes side effects. After a month, if she tolerates it well, we could increase her to a weekly dose of 1 mg.
Switching from Trulicity (dulaglutide) to Mounjaro (tirzepatide): After her last dose of Trulicity, we would wait a full week (a “washout” period) before starting tirzepatide. I would initiate treatment with tirzepatide 5 mg weekly. The goal is to find the optimal dose—the one where the patient achieves significant satiety and weight loss with minimal side effects—by titrating up every four weeks if needed.

The Expanding Universe of GLP-1 Receptor Agonists

The story of GLP-1 agonists is no longer confined to diabetes. The research community is buzzing with discoveries about their far-reaching benefits.

Metabolically Associated Steatotic Liver Disease (MASLD)

One of the most promising frontiers is in liver health. The primary benefit for MASLD and its inflammatory progression, MASH, comes from the significant and sustained weight loss these drugs induce, which directly decreases fat deposition in the liver (Abbasi, 2024). Novo Nordisk is seeking FDA approval for this indication, which we may see by late 2025 or early 2026.

Expanding Indications: Beyond Diabetes

The benefits have proven to extend beyond patients with type 2 diabetes, as established by two landmark trials:
STEP-HFpEF Trial: This study showed that in patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide led to significant improvements in heart failure symptoms and physical limitations, regardless of whether the patients had diabetes (Kosiborod et al., 2023).
SELECT Trial: This trial involved over 17,000 overweight or obese patients with pre-existing heart disease but without diabetes. The group receiving semaglutide showed a 20% reduction in MACE compared to placebo.

Cravings, Compulsive Behaviors, and Addiction

A consistent report from my own patients is a dramatic reduction in cravings. They describe it as a quieting of the constant “food noise” in their brain, with a decreased desire for alcohol and smoking. This points to a fundamental impact on the brain’s reward pathways.

PCOS, Fertility, and the “Ozempic Babies” Phenomenon

For many women with Polycystic Ovary Syndrome (PCOS), the substantial weight loss from these drugs can restore metabolic balance and regulate menstrual cycles. This has led to enhanced fertility and the recent media phenomenon of “Ozempic babies.”

Other Investigational Uses

Researchers are also observing positive effects in:
Neuroprotection: Patients with dementia and Parkinson’s disease have shown a stall in disease progression, suggesting a neuroprotective effect within the brain.
Latent Autoimmune Diabetes in Adults (LADA): The off-label use of GLP-1 agonists is being studied to help preserve remaining beta-cell function in this form of autoimmune diabetes (Buzzetti et al., 2020).
Respiratory Health: In patients with asthma and COPD, these drugs have been associated with fewer exacerbations, likely due to their anti-inflammatory properties.

The Role of Integrative Chiropractic Care

This is where my perspective as a DC, APRN, and Functional Medicine Practitioner becomes so important. While these medications are incredibly powerful, they are tools, not cures. True, lasting health is achieved when we combine these advanced pharmacotherapies with a foundation of lifestyle and structural wellness.
Optimizing Nervous System Function: The nervous system is the body’s master controller. The gut-brain axis is a two-way communication highway critical for satiety signaling. Chiropractic adjustments can help reduce nerve interference, potentially enhancing the body’s response to these signals and improving the efficiency of the gut-brain connection.
Supporting Musculoskeletal Health During Weight Loss: Rapid and significant weight loss can place new stresses on the body as a patient’s center of gravity shifts. This can lead to new patterns of musculoskeletal pain. Integrative chiropractic care is crucial for managing these biomechanical changes through targeted adjustments, soft-tissue work, and the prescription of corrective exercises.
Addressing the Root Causes: Functional medicine teaches us to ask “Why?” We use a holistic approach to craft personalized nutrition plans, develop sustainable exercise regimens that preserve muscle mass, and implement stress-management techniques to reduce cortisol levels.
Chiropractic care is not an alternative to these medications; it is a vital complement. By ensuring the body’s structure and nervous system function optimally, we create an environment in which these powerful drugs can work most effectively.

Safety, Side Effects, and Practical Recommendations

While transformative, these medications require careful management.

Common GI Side Effects

Nausea: This is the most common side effect, often linked to early satiety.
Constipation or Diarrhea: The effect on motility varies by individual.
Management Strategy: The key is to “start low and go slow.” I start patients on the lowest possible dose for at least a month before considering an increase.

Important Safety Issues

Gallbladder Events: Rapid weight loss can increase the risk of gallstones.
Acute Kidney Injury: Can occur from severe nausea and vomiting leading to dehydration. Staying well-hydrated is critical.
Pancreatitis: Though rare, patients with severe, persistent abdominal pain should seek immediate medical attention.
Surgical Considerations: Anesthesiology guidelines recommend stopping weekly GLP-1 agonists at least one to two weeks before a planned surgery to reduce the risk of aspirating stomach contents.
Muscle and Bone Mass: Significant weight loss involves some loss of lean muscle and bone. I work with patients to incorporate resistance training and ensure adequate protein intake.

Black Box Warning: Thyroid C-Cell Tumors

These medications carry a black box warning regarding the risk of thyroid C-cell tumors observed in rodent studies. While this link has not been established in humans, the drugs are contraindicated in patients with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Final Thoughts: A New Hope for Patients

The advent of modern GLP-1 receptor agonists has fundamentally changed the landscape of diabetes and metabolic care. For patients like Naomi, starting a GLP-1 agonist is not just about adding another medication; it’s about shifting her disease trajectory. It offers the potential to achieve her A1c goal, lose significant weight, reduce her reliance on insulin, and lower her risk of a future heart attack or stroke.
As healthcare providers, it is our responsibility to embrace a comprehensive, integrative approach. By combining the power of these advanced medications with the foundational principles of lifestyle medicine and chiropractic care, we can offer our patients a new level of hope and empower them to achieve a healthier, more vibrant future.

References


SEO Tags: GLP-1 agonists, Semaglutide, Tirzepatide, Ozempic, Mounjaro, Wegovy, Zepbound, Type 2 Diabetes, Weight Loss, Cardiovascular Risk Reduction, Integrative Chiropractic Care, Functional Medicine, Dr. Alexander Jimenez, El Paso Chiropractor, A1c, Postprandial Glucose, Incretin Effect, Metabolic Health, Heart Health, Kidney Disease, CVOT, Ominous Octet, Gastric Emptying, Satiety, MASH, neuroprotection, PCOS, fertility, LADA, patient-centered care, cardio-renal-metabolic health, chiropractic adjustment, musculoskeletal health

Bioidentical Hormone Replacement Therapy

Bioidentical Hormone Replacement Therapy

Whole-Body Wellness: An Integrative Guide

At ChiroMed, the message is clear: good care should not stop at symptom control. The clinic describes itself as an integrative medicine practice in El Paso that brings together chiropractic care, nurse practitioner services, naturopathy, rehabilitation, nutrition counseling, and acupuncture to identify root causes and develop personalized treatment plans. That kind of model fits Bioidentical Hormone Replacement Therapy, or BHRT, very well because hormone symptoms often overlap with thyroid, metabolic, gut, sleep, and stress issues. (ChiroMed, n.d.-a, n.d.-b.)

BHRT uses hormones that are chemically identical to those your body naturally produces. Common examples include estrogen, progesterone, and testosterone. Some treatment plans may also look at DHEA or thyroid-related issues when symptoms and lab work point in that direction. People usually seek BHRT because they are dealing with fatigue, low libido, poor sleep, mood swings, brain fog, hot flashes, vaginal dryness, or weight changes that may be tied to hormone decline or imbalance. (Cleveland Clinic, 2022; Meeting Point Health, n.d.)

What Makes BHRT Different

The main idea behind BHRT is exact-match hormone support. These hormones are often plant-derived, then processed so their molecular structure matches human hormones. That is why many patients and clinicians see BHRT as a more personalized option. Still, it is important to stay medically precise: being bioidentical does not automatically mean risk-free. Cleveland Clinic notes that some bioidentical hormones are FDA-approved, while many compounded products are not. That difference matters when people are choosing between convenience, customization, and safety oversight. (Cleveland Clinic, 2022; Endocrine Society, 2019.)

An easy way to understand BHRT is to think of it as one tool in a larger health plan, not a magic fix. It can help the right patient, but it works best when it is matched to symptoms, medical history, lab data, and ongoing follow-up. That whole-person view aligns with the ChiroMed style of care, where the goal is to connect the dots among pain, energy, digestion, function, and overall wellness rather than chasing a single number or complaint. (ChiroMed, n.d.-a; EVEXIAS Health Solutions, n.d.-a.)

Why Thyroid and Metabolic Health Matter

One reason BHRT should be handled carefully is that sex hormones do not work alone. Thyroid function, adrenal stress, inflammation, nutrient status, sleep quality, and insulin balance all affect how a person feels. Potter’s House Apothecary notes that thyroid and adrenal function, along with nutritional status, should also be evaluated when treating hormone imbalance. Similarly, ChiroMed’s educational content highlights how thyroid activity, inflammation, and nutrient status can affect energy and metabolism. (Potter’s House Apothecary, n.d.; ChiroMed, 2026.)

This is why a patient who says, “I am tired all the time,” may need more than hormone pellets or cream. Fatigue can come from low estrogen, low testosterone, thyroid dysfunction, poor sleep, high stress, gut irritation, nutrient gaps, or a mix of several issues. A clinic that uses integrated medicine is better positioned to sort through those layers. That is one reason this topic fits ChiroMed so well. Its model combines structural care, functional medicine, and personalized nutrition rather than treating hormones as a stand-alone issue. (ChiroMed, n.d.-a; ChiroMed, 2025.)

The EVEXIAS and EvexiPEL Approach

EVEXIAS Health Solutions is widely known for its EvexiPEL pellet system. According to the company, the method uses tiny hormone pellets placed just under the skin during a simple in-office procedure. EVEXIAS says the pellets then release a steady physiologic dose of hormones over about 3 to 6 months. The company presents the treatment as a long-acting option that may reduce the ups and downs some patients notice with daily or short-acting delivery methods. (EVEXIAS Health Solutions, n.d.-b.)

EVEXIAS also frames hormone care as more than just pellet insertion. Its official materials explain that hormone care involves a wider approach that includes hormone testing, hormone optimization therapy, peptide therapy, nutraceuticals, functional and integrated health solutions, and support for both men’s and women’s health. The company also states that lasting wellness requires more than hormones alone, which is why it pairs BHRT with targeted nutrition and other supportive strategies. That philosophy aligns closely with the kind of full-spectrum care ChiroMed promotes on its website. (EVEXIAS Health Solutions, n.d.-a.)

Why ChiroMed Is a Strong Fit for This Topic

ChiroMed describes itself as an integrated medicine clinic that blends conventional and alternative care under one roof. On its site, the clinic highlights chiropractic care, nurse practitioner services, naturopathy, rehabilitation, nutrition counseling, and acupuncture as part of one coordinated system. For patients dealing with a possible hormone imbalance, that matters because recovery often depends on more than replacing one hormone. It may also depend on reducing pain, improving sleep, supporting digestion, correcting nutrient gaps, and improving day-to-day function. (ChiroMed, n.d.-a, n.d.-b.)

Dr. Alexander Jimenez’s clinical education also supports this broader view. In a treatment guide hosted on his site, he notes that functional medicine evaluation should be individualized and often includes more than hormone testing alone, such as thyroid hormones, CBC, CMP, and vitamin D. In simple terms, that means hormone symptoms should be interpreted in the context of the rest of the body. That is a practical and patient-centered way to think about BHRT. (Jimenez, 2025.)

A ChiroMed-style BHRT evaluation would make sense when it includes:

  • a full symptom review
  • hormone testing when appropriate
  • thyroid and metabolic screening
  • medication and supplement review
  • nutrition and gut health support
  • sleep and stress assessment
  • exercise and recovery planning
  • follow-up visits to adjust care safely

This kind of structure helps move BHRT away from one-size-fits-all prescribing and toward personalized, integrated care. (ChiroMed, 2025; EVEXIAS Health Solutions, n.d.-a; Potter’s House Apothecary, n.d.)

Gut Health and Hormone Balance

Many patients notice that hormone problems and gut complaints show up together. That does not mean BHRT directly cures digestive issues. It does mean gut health deserves attention when symptoms overlap. ChiroMed’s functional medicine content repeatedly connects digestion, nutrition, inflammation, and nervous system balance to overall wellness. EVEXIAS also promotes nutraceutical support for gut health as part of its broader hormone optimization ecosystem. A practical takeaway for patients is that bloating, constipation, fatigue, and low energy should be evaluated in context rather than blamed on hormones alone. (ChiroMed, 2025; EVEXIAS Health Solutions, n.d.-a.)

That is also where an integrated clinic can help more than a simple hormone refill service. ChiroMed’s telemedicine and integrative pages describe a system in which providers review health history, use testing as needed, and combine nutrition, chiropractic care, and functional support into a single plan. When a patient has both low energy and digestive complaints, that kind of model makes it easier to ask the right questions about inflammation, food triggers, thyroid status, and hormone balance together. (ChiroMed, 2025.)

Safety, Side Effects, and Monitoring

BHRT should always be treated as a legitimate medical therapy. Cleveland Clinic states that hormone therapy can raise the risk of blood clots, stroke, gallbladder disease, and possibly heart disease or breast cancer in some settings, especially depending on age, duration, and the product used. Common side effects may include weight gain, tiredness, acne, headaches, breast tenderness, bloating, cramping, spotting, and mood swings. These risks do not mean BHRT is never appropriate. They do mean treatment should be individualized and monitored. (Cleveland Clinic, 2022.)

The strongest caution in the medical literature is often directed at compounded products marketed as safer simply because they are labeled “bioidentical.” The Endocrine Society states that there is little or no scientific evidence showing compounded bioidentical hormone therapy is safer or more effective than FDA-approved therapy. It also warns that compounded formulations may vary in dose and purity because they are not regulated the same way as FDA-approved hormone products. Cleveland Clinic makes a similar point. (Endocrine Society, 2019; Cleveland Clinic, 2022.)

Monitoring is just as important as prescribing. Vitality Family Health notes that follow-up should focus on symptom response, physical examinations, and side effects rather than trying to force patients to achieve a single “perfect” lab value. That idea fits with integrative medicine. The goal is not just to change a blood test. The goal is to help the patient feel better, function better, and stay safe while the treatment plan is adjusted over time. (Vitality Family Health, 2025.)

A Practical ChiroMed Message for Patients

For a ChiroMed audience, the best message is simple: BHRT can be helpful, but it should be part of a broader plan. Patients do best when clinicians ask why symptoms are happening, not just how to cover them up. That means looking at hormones, thyroid function, nutrition, digestion, sleep, pain, stress, and movement patterns together. It also means using careful follow-up and realistic expectations instead of promising instant results. (ChiroMed, n.d.-a; Jimenez, 2025; Cleveland Clinic, 2022.)

In that setting, BHRT becomes more than a prescription. It becomes one piece of a personalized strategy to restore balance, improve energy, support metabolism, and help patients move toward long-term wellness. That whole-body approach is exactly the kind of tone and clinical direction that fits the ChiroMed brand. (ChiroMed, n.d.-b; EVEXIAS Health Solutions, n.d.-a.)


References

Systemic-inflammation-cell-fascia

Cellular Health and Fascia Wellness From Systemic Inflammation

Understand the importance of cellular health and fascia in managing systemic inflammation. Enhance your wellness journey today.


By Dr. Alex Jimenez, DC, FNP-APRN

Introduction: Charting the Course for a Longer, Healthier Life

Welcome to this in-depth exploration of the new frontier in longevity and cellular health. As a practitioner dedicated to both the structural and systemic aspects of human wellness, holding credentials as a Doctor of Chiropractic (DC) and a Family Nurse Practitioner (FNP-APRN), I have always been driven by a singular mission: to integrate the most advanced, evidence-based research into practical, effective clinical strategies. This post is the culmination of that mission, designed to distill complex, cutting-edge science into a clear, actionable framework for health. We are moving beyond the traditional, fragmented view of the body and embracing a holistic, interconnected systems-based approach. We will not be talking in hypotheticals; instead, we will present the latest findings from leading researchers in the field, showcasing their work through modern, evidence-based research methods to illuminate the path toward a longer, more vibrant life.

In the sections that follow, we will embark on a comprehensive journey into the very fabric of our being. We will begin by demystifying the concept of aging itself, reframing it not as an inevitable decline but as a modifiable process rooted in what modern science calls the “Hallmarks of Aging.” A central theme will be the concept of “inflammaging,” the chronic, low-grade inflammation that silently accelerates the aging process and underlies nearly every chronic disease. We will discuss why establishing a baseline of your unique biological data from a young age is no longer a luxury but a necessity for predictive and personalized medicine.

From there, our exploration will dive deep into the fascinating world of the fascial system—the body’s ubiquitous connective tissue network. Once dismissed as mere “packing material,” fascia is now recognized as a primary sensory and communication organ, a “body-wide web” that influences everything from our posture and movement to our immune function and cellular health. We will unpack the intricate physiology of fascia, its relationship with the extracellular matrix (ECM), and the pivotal role of its health in optimal cellular signaling, nutrient exchange, and waste removal. You will learn how the fascial system can become dense and fibrotic due to injury, stress, and inflammation, creating a “cellular prison” that perpetuates dysfunction and pain.

A significant portion of our discussion will focus on the immune system’s intimate relationship with the fascial network and the ECM. We will examine how immune cells, such as macrophages, lymphocytes, and mast cells, reside within and are influenced by this matrix. We will explore the Cell Danger Response (CDR), a universal metabolic response to threat, and how a persistent CDR can lead to chronic inflammation and a breakdown in immune tolerance, setting the stage for autoimmune conditions and accelerated aging. This will lead us to a critical analysis of modern metabolic health, particularly the hidden dangers of hyperinsulinemia and its devastating impact on cellular function, even in individuals with “normal” blood sugar. We’ll present a compelling case for why measuring fasting insulin alongside glucose is a non-negotiable aspect of any true health assessment.

Finally, we will translate this deep physiological understanding into practical, evidence-based interventions. We will critically evaluate therapies such as cryotherapy (cold treatment) and thermotherapy (heat therapy), moving beyond simplistic advice to provide nuanced guidelines for their proper application in acute injury versus chronic remodeling. We will also touch on the powerful potential of targeted interventions such as peptides (e.g., BPC-157) and photobiomodulation (red light therapy) to support tissue repair, modulate the immune system, and restore cellular homeostasis. Throughout this post, my goal is to empower you with knowledge—to help you understand the why behind the what, so you can become a more informed and active participant in your own health journey. This is not about chasing fads; it is about building a foundation of resilient health based on the profound and elegant principles of human physiology.


Redefining Aging: From Inevitability to a Modifiable Process

For centuries, we’ve viewed aging as a one-way street of inevitable decline. However, a seismic shift is occurring in medical science. We are beginning to understand aging not merely as the passage of time, but as a specific, definable biological process characterized by a collection of interconnected dysfunctions known as the “Hallmarks of Aging.” This perspective is revolutionary because it reframes aging as a condition that can be studied, understood, and, most importantly, modified.

The conversation has moved from “how long we live” to “how well we live” for the duration of our lives—our healthspan. The goal is no longer to add years to life, but to add life to our years. This involves actively working to re-function, regenerate, and create resilience within our own biology.

The Critical Importance of a Biological Baseline

One of the most foundational principles of this new paradigm is establishing a biological baseline. Imagine trying to navigate a complex journey without a map or a starting point. That’s precisely what we do when we wait for a disease to manifest before taking a deep look at our health.

When I work with patients, whether they are young children or their aging parents, the first and most crucial step is to capture a comprehensive snapshot of their current physiological state. This isn’t just a standard physical; it’s a deep dive into their molecular and cellular world. This baseline becomes our immutable point of reference.

For example, if a patient comes to me today, in 2024, and we run a comprehensive panel of biomarkers, that data is locked in. If they return in 2026 after experiencing a health challenge or simply as part of a proactive monitoring plan, we don’t have to guess what “normal” looks like for them. We can compare their new results directly to their unique baseline. This allows us to detect subtle shifts and deviations long before they snowball into a full-blown clinical diagnosis. It’s the essence of predictive and preventative medicine.

Ideally, this process should begin in youth. By understanding an individual’s genetic predispositions and establishing their unique physiological “signature” early on, we create a roadmap for a lifetime of personalized health optimization. This is about being in a constant state of readiness. Like a well-prepared military, we aren’t waiting for a crisis to happen; we are building the resources and intelligence to anticipate and mitigate threats before they escalate.

Aging as an Informational Problem: Senescence and Geriatric Genes

At its core, aging can be viewed as an informational problem. Our DNA is the blueprint, but it’s the epigenome—the layer of chemical tags that tells our genes when to turn on and off—that acts as the software. Over time, due to environmental insults, lifestyle factors, and metabolic dysfunction, this “software” can become corrupted.

This leads to a phenomenon called cellular senescence, where cells lose their ability to divide and function properly. These “zombie cells” don’t just sit there quietly; they secrete a cocktail of inflammatory signals known as the Senescence-Associated Secretory Phenotype (SASP), which poisons the surrounding tissue environment and accelerates the aging of neighboring cells.

This is an informational breakdown. The cell’s internal programming has been disrupted. For example, in an aging liver or ovary, the epigenetic signals can begin to turn on what we might call “geriatric genes”—genes that promote fibrosis, inflammation, and a loss of functional capacity. Our goal is to maintain the integrity of that original, youthful genetic “software” for as long as possible. Understanding a person’s baseline is the first step in monitoring and protecting that precious informational code.


The Fascial System: Your Body’s Intelligent, Interconnected Web

If we are to understand health and longevity truly, we must look beyond individual organs and systems and appreciate the tissue that connects them all: fascia. For too long, fascia was dismissed in anatomy labs as the white, fibrous “stuff” that you had to cut through to get to the “important” structures like muscles and organs. Modern research, however, has unveiled fascia as one of the most vital and intelligent systems in the body.

Think of it as a continuous, body-wide tensional network that exists from head to toe, from skin to bone. It’s not just a series of disconnected sheets; it’s a single, uninterrupted web. This web has three main layers:

  1. Superficial Fascia: Located just beneath the skin, rich in fat, nerves, and blood vessels.
  2. Deep Fascia: The dense, fibrous layer that envelops and separates muscles, bones, and organs, forming compartments and transmitting mechanical force.
  3. Visceral Fascia: The layer that surrounds and suspends our organs within their cavities.

But it goes even deeper. Fascia continues into the structures it surrounds. The connective tissue wrapping a muscle (epimysium), a muscle bundle (perimysium), and even a single muscle fiber (endomysium) are all part of this continuous fascial matrix. It even extends to the covering of our nerves (epineurium, perineurium, endoneurium). It is, in every sense, the fabric that holds us together.

Fascia as a Primary Sensory and Communication Organ

Perhaps the most groundbreaking discovery is that fascia are among our richest sensory organs. It is densely populated with mechanoreceptors—nerve endings that sense pressure, tension, and movement. In fact, it’s estimated that the fascial network contains a staggering number of sensory nerve endings, potentially rivaling or even exceeding that of the retina. Some leading researchers, like Dr. Robert Schleip, posit that up to 80% of our interoceptive information—the sense of our body’s internal state—originates from the sensory nerves embedded in our fascia, not just from our muscles.

This has profound implications. When you feel “stiff,” “tight,” or have a poor sense of your body’s position in space, you are receiving signals from your fascial network. This system is constantly communicating with the central nervous system, providing a real-time feedback loop on our mechanical status, hydration levels, and overall physiological well-being. It is the physical substrate of our mind-body connection. Energy and information travel through this network at incredible speed. While we are roughly 70% water by weight, the molecules that make up our bodies are 99% water molecules. This aqueous, crystalline matrix of the fascia is the perfect medium for conducting bioelectric and mechanical signals.

Fascial Lines and the Transmission of Force

Fascia is not arranged randomly. It organizes itself along lines of tension, creating what pioneers like Tom Myers have termed “Anatomy Trains” or myofascial meridians. These are continuous lines of fascial connection that link different parts of thebody.

A classic example is the Superficial Back Line, which runs from the bottom of your feet, up the calves and hamstrings, over the sacrum, up the erector spinae muscles, and over the top of the skull to your eyebrows. This explains why tension in your feet can contribute to headaches, or why tightness in your hamstrings can cause low back pain.

Another crucial line is the Spiral Line, which loops around the body like a double helix, connecting, for example, the left shoulder to the right hip. This is the line that governs rotational movements, like throwing a ball or walking. An imbalance or restriction anywhere along this line will compromise the efficiency and fluidity of the entire chain. This is why a therapist might work on your hip to resolve a shoulder problem—they are not treating the site of pain, but the source of the dysfunction within the interconnected fascial web. This interconnectedness is the very reason why a holistic approach to the body is not just a philosophy, but a physiological necessity.


The Extracellular Matrix (ECM): The Cellular Neighborhood

To understand how fascia influences health at the most fundamental level, we must zoom in from the macroscopic fascial planes to the microscopic environment surrounding every cell in our body: the Extracellular Matrix (ECM). The ECM is the non-cellular component of all tissues. If the cells are the residents of a neighborhood, the ECM is the entire infrastructure—the roads, communication lines, waste-disposal systems, and public parks.

The ECM is a complex, gel-like substance primarily produced and maintained by cells called fibroblasts. It is composed of a rich “cocktail” of molecules, including:

  • Collagen: The primary structural protein, providing tensile strength and stability. There are many types, with Type I being the most abundant and providing rigidity. At the same time, Type III (reticular collagen) is finer and more flexible, often found in new tissue and during the early stages of wound healing.
  • Elastin: A protein that allows tissues to stretch and recoil, providing elasticity.
  • Proteoglycans and Glycosaminoglycans (GAGs): These are large molecules (like hyaluronic acid) that attract and hold vast amounts of water, creating the hydrated, gel-like consistency of the ECM. This hydration is critical for shock absorption and for facilitating the diffusion of nutrients and signaling molecules.

The ECM is not passive scaffolding. It is a dynamic, biologically active environment in constant, bidirectional communication with the cells living within it. Cells use the ECM to impart strength and shape to tissues, but the ECM, in turn, dictates cell behavior. It provides physical and biochemical cues that influence cell differentiation, migration, proliferation, and survival. Hormones, growth factors, and cytokines all travel through and are modulated by the ECM to reach their target cells.

When the Neighborhood Goes Bad: Fibrosis and the Cell Danger Response

In a healthy state, the ECM is a fluid, adaptable, and resilient environment. However, following injury, chronic inflammation, or metabolic stress, this neighborhood can become a very hostile place.

This is where the Cell Danger Response (CDR) comes into play. The CDR, a concept brilliantly articulated by Dr. Robert Naviaux, is a universal, evolutionarily conserved metabolic response that a cell initiates when it perceives a threat—be it a virus, a toxin, or a physical injury. The cell essentially shifts its priorities from “peacetime” functions (growth, repair, social interaction with other cells) to “wartime” functions (defense). It hunkers down, hardens its membrane, and changes its metabolism.

If this threat is acute and resolved quickly, the cell returns to its normal state. But if the danger is chronic—persistent inflammation, ongoing metabolic stress, unresolved emotional trauma—the CDR can get “stuck” in the “on” position. This has devastating consequences for the ECM.

In a state of chronic CDR, cells like fibroblasts are signaled to go into overdrive. They begin to churn out excessive amounts of collagen, particularly the thick, rigid Type I collagen. They also produce enzymes that cross-link these fibers, making the ECM dense, stiff, and fibrotic. The once-fluid, gel-like matrix becomes more like hardened cement.

This densification and fibrosis of the fascia and ECM create a “cellular prison.”

  1. Impaired Communication: The stiff matrix physically blocks the flow of signaling molecules, nutrients, and oxygen to the cells.
  2. Waste Accumulation: Metabolic waste products cannot be efficiently cleared, creating a toxic local environment. This further lowers the local pH, making the tissue more acidic, which in itself is a powerful inflammatory signal.
  3. Mechanical Entrapment: Nerves and blood vessels become compressed and entrapped within this fibrotic tissue, leading to pain, numbness, and ischemia (lack of blood flow).
  4. Perpetuating Inflammation: The stiff ECM itself sends pro-inflammatory signals back to the cells, creating a vicious, self-perpetuating cycle of inflammation and fibrosis. This is a key driver of conditions like hyperalgesia (an amplified pain response) and sustained inflammation seen in chronic pain syndromes.

This process is not limited to musculoskeletal injuries. It is the same fundamental pathology we see in a fibrotic liver (cirrhosis), hardened arteries (atherosclerosis), and the tissue damage following chemotherapy or radiation. Understanding how to address and remodel this dysfunctional ECM is a cornerstone of true healing and longevity.


The Immune System’s Role in Fascia and the ECM

The immune system and the fascial/ECM network are inextricably linked. The ECM is not just a passive scaffold; it is a primary residence and playground for a vast array of immune cells. This is where the body’s surveillance and defense operations are headquartered.

Key immune cells that reside within the fascial matrix include:

  • Macrophages: the “clean-up crew” of the immune system. They patrol the ECM, engulfing cellular debris, pathogens, and senescent cells. They are also master regulators, capable of shifting their phenotype (behavior) from a pro-inflammatory (M1) state to an anti-inflammatory and pro-repair (M2) state. The state of the ECM heavily influences this shift.
  • Mast Cells: These cells are packed with granules containing potent signaling molecules like histamine and cytokines. When they degranulate in response to an injury or allergen, they initiate the inflammatory cascade, increasing blood vessel permeability and recruiting other immune cells to the site.
  • Lymphocytes (T cells and B cells): These are the cells of the adaptive immune system. They infiltrate tissues from the bloodstream in response to specific threats, orchestrating targeted attacks and creating immunological memory.
  • Dendritic Cells: These are the “scouts” that sample the environment for foreign invaders. They capture antigens and present them to T cells in lymph nodes, thereby initiating a specific immune response.

In a healthy state, these cells work in a beautifully orchestrated symphony. Following an acute injury, they mount a controlled inflammatory response to clear the damage and then transition to a pro-resolving phase to facilitate healing and remodeling of the ECM. This process is called immune tolerance and resolution.

Breaking the Tolerance: From Acute Inflammation to Chronic Disease

The problem arises when this process becomes dysregulated. In the context of a chronically stuck Cell Danger Response and a fibrotic ECM, the immune system’s behavior changes dramatically.

  1. Vicious Cycle: The stiff, acidic, and hypoxic (low oxygen) ECM sends danger signals that keep macrophages in a pro-inflammatory M1 state. These M1 macrophages, in turn, release cytokines that stimulate fibroblasts to produce even more fibrotic tissue, perpetuating the cycle.
  2. Loss of Tolerance: The normal resolution process fails. The immune system remains on high alert. T regulatory cells, which are supposed to pump the brakes on the immune response by releasing anti-inflammatory signals such as IL-10, become suppressed or ineffective.
  3. Auto-reactivity: Chronic inflammation and tissue damage can expose “self-antigens”—proteins normally hidden from the immune system. This can trigger a case of mistaken identity, where the immune system begins to attack the body’s own tissues, leading to autoimmune diseases.

This breakdown of immune tolerance is a central driver of aging and chronic disease. It is the link between a local injury and systemic dysfunction. For example, a “leaky gut” (intestinal barrier hyperpermeability) allows bacterial components, such as lipopolysaccharide (LPS), to enter the bloodstream. This systemic inflammatory trigger can then break down the blood-brain barrier, allowing inflammation to spill into the central nervous system and activate microglia (the brain’s resident immune cells), contributing to neuroinflammation, brain fog, and chronic fatigue. The principles are universal: a breakdown in a barrier, a loss of immune tolerance, and a vicious cycle of inflammation.

The Case of the 19-Year-Old Woman: A Lesson in Immune Dysregulation

To make this tangible, let me share a clinical example. I recently worked with a 19-year-old young woman whose parents were concerned about her neurodivergent tendencies and a general lack of vitality. Her standard blood work was largely unremarkable, but a deeper dive revealed a story of profound immune dysregulation.

Her neutrophil count was persistently elevated. While neutrophils are our first responders to acute infection, chronically high levels suggest a state of sterile, low-grade inflammation. A closer look at her lymphocyte subsets and viral antibody panels told the real story. She had sky-high IgG antibodies to Epstein-Barr Virus (EBV).

Now, many people have been exposed to EBV. But her pattern was different. She had elevated antibodies to multiple viral components (VCA, EA, and EBNA), indicating a chronic, poorly controlled viral reactivation. Her immune system was “stuck” fighting a ghost. This constant battle was consuming vast amounts of energy and resources, contributing to her fatigue and neurological symptoms. Her immune system was unable to achieve resolution. It was locked in a state of perpetual, ineffective warfare, and her fascial and extracellular matrix environment was undoubtedly paying the price, becoming progressively more inflamed and dysregulated. This case highlights why we cannot look at any one system in isolation. Her neurological symptoms were a direct reflection of her immune dysregulation.


Metabolic Health: The Unseen Driver of Cellular Dysfunction

No discussion of cellular health and longevity is complete without a deep dive into metabolism, and specifically, the role of insulin. We live in an epidemic of metabolic dysfunction, and much of it is hidden, lurking beneath the surface of “normal” blood sugar readings.

The standard American diet, laden with processed carbohydrates and sugars, forces the pancreas to pump out large amounts of insulin to shuttle glucose out of the bloodstream and into cells. Over time, cells become resistant to this constant hormonal shouting. They “turn down the volume” on their insulin receptors. This is insulin resistance.

In response, the pancreas has to shout even louder, producing even more insulin to get the job done. This condition is called hyperinsulinemia (high insulin levels). For years, even decades, this compensatory mechanism can keep blood glucose levels in the “normal” range. The person’s A1C might be 5.5, and their fasting glucose might be 95 mg/dL. Their doctor tells them everything is fine.

But everything is not fine.

The Hidden Opportunity for Intervention

This period of “normoglycemic hyperinsulinemia” is a massive, missed opportunity for intervention. Insulin is a potent pro-growth and pro-inflammatory hormone. Chronically high levels of insulin are a powerful driver of the negative changes we’ve been discussing:

  • It promotes fat storage, particularly in the form of inflammatory white adipose tissue (WAT).
  • It directly stimulates inflammatory pathways.
  • It contributes to cell proliferation and can accelerate cancer growth.
  • It damages the endothelium (the lining of blood vessels), driving atherosclerosis.
  • It fuels the inflammatory processes within the ECM.

This is why it is absolutely critical to measure fasting insulin alongside fasting glucose and HbA1c. A fasting insulin level above 8 μIU/mL, and certainly above 10, is a major red flag, even if glucose is normal. I once had a physician patient whose fasting glucose was only 100 mg/dL, but his fasting insulin was over 30. He was on the brink of a metabolic catastrophe and didn’t even know it. This wasn’t a knowledge gap; it was a measurement gap. By addressing his profound hyperinsulinemia with targeted dietary changes, we averted a crisis.

The popular GLP-1 agonists work by improving insulin sensitivity and promoting satiety. While they can be powerful tools, they should never be used in a vacuum. If the underlying lifestyle and dietary habits that drive insulin resistance are not addressed, these drugs become a mere crutch. The foundation must be restoring the body’s natural insulin sensitivity through whole foods, proper nutrient timing, and movement. For example, simply adding glycine, an amino acid that can improve insulin signaling, can be a supportive measure alongside these broader strategies.


The Non-Surgical Approach to Wellness with Chiropractic Care- Video


Practical Interventions: Modulating the Fascial-Immune-Metabolic Axis

Understanding this complex interplay among the fascial system, the immune system, and our metabolism enables us to be much more strategic and precise in our interventions. The goal is to break the vicious cycles of inflammation and fibrosis and restore the body’s innate capacity for healing and resolution.

Heat and Cold: A Nuanced Approach

Thermotherapy (heat) and cryotherapy (cold) are ancient and powerful tools, but they are often used indiscriminately. Their effects are profoundly different, and their application must be timed correctly.

  • Cold Therapy (Cryotherapy): Cold causes vasoconstriction (narrowing of blood vessels) and has a potent acute anti-inflammatory effect. It slows down metabolic processes and reduces the initial swelling and pain signals immediately following an injury. Therefore, cold is best used for acute problems. Think of an athlete who just sprained their ankle. A short, targeted cold application can be very beneficial in the first 24-48 hours.
  • However, chronic, long-term use of cold can be counterproductive to healing. By persistently suppressing inflammation, you also suppress the signals necessary for repair and remodeling. You are essentially hitting the “pause” button on the healing process. Short-term application is key.
  • Heat Therapy (Thermotherapy): Heat causes vasodilation (widening of blood vessels), increasing blood flow to an area. This is crucial for the remodeling phase of healing. Increased blood flow brings in the oxygen and nutrients needed for fibroblasts to lay down new, healthy ECM. It also helps to flush out metabolic waste products that have accumulated in the area.
  • Therefore, heat is best used for chronic conditions, stiffness, and to promote the later stages of tissue repair after the acute inflammatory phase has subsided. It helps to make the fascial matrix more pliable and supports the long-term process of restoring tissue quality.

Clinical Guideline:

  • Acute Phase (0-72 hours post-injury): Use short-term, intermittent cold therapy to manage pain and swelling.
  • Subacute/Chronic Phase (After 72 hours): Transition to heat therapy to promote blood flow, tissue relaxation, and remodeling. Avoid daily, habitual cold plunging if your goal is tissue repair and adaptation.

Beyond Temperature: Photobiomodulation and Peptides

Modern science offers even more targeted ways to influence this system.

  • Photobiomodulation (PBM) / Red Light Therapy: This involves exposing the body to specific wavelengths of red and near-infrared light. The mitochondria, the powerhouses of our cells, absorb this light energy. The primary effect is to stimulate ATP production (cellular energy) and, in a controlled manner, transiently increase reactive oxygen species (ROS), triggering the body’s antioxidant and repair mechanisms. PBM can reduce inflammation, stimulate fibroblast activity for healthy collagen production, improve circulation, and modulate the immune response. It is a powerful tool for changing the phenotypic expression of cells—shifting them from a “danger” state to a “healing” state.
  • Peptides: Peptides are short chains of amino acids that act as precise signaling molecules. They offer a way to give the body specific instructions. For example, BPC-157 (Body Protection Compound-157) is a peptide that has been shown in extensive research to accelerate the healing of a wide variety of tissues—muscle, tendon, ligaments, and even the gut lining. It appears to work by promoting angiogenesis (the formation of new blood vessels), modulating growth factor signaling, and protecting the endothelial barrier. When dealing with a “leaky gut” or a chronic tendon injury, BPC-157 can be a remarkable tool for restoring barrier integrity and facilitating repair.

The ultimate strategy involves a multi-pronged approach. We must change the terrain. This means cleaning up the diet to reverse hyperinsulinemia, using strategic movement to hydrate and mobilize the fascia, managing stress to calm the nervous system, and then layering in targeted therapies like PBM or peptides to provide the specific signals the body needs to break out of chronic dysfunction and re-engage its powerful, innate healing programs.


Disclaimer

The information contained in this educational post is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. It is not intended for self-diagnosis or to replace a qualified healthcare professional’s consultation. Dr. Alex Jimenez, DC, FNP-APRN, is not your medical provider. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this web page. All individuals must obtain recommendations for their personal situations from their own medical providers. Reliance on any information provided in this post is solely at your own risk.


Summary, Conclusion, and Key Insights

Summary

This educational post has provided a comprehensive overview of a modern, systems-based approach to health, longevity, and the treatment of chronic conditions. We began by redefining aging as a modifiable biological process, emphasizing the critical need for establishing a physiological baseline early in life for predictive and personalized medicine. We then delved into the profound importance of the fascial system and the Extracellular Matrix (ECM), recasting them as a dynamic, body-wide sensory and communication network rather than passive structural elements. We explored how this network’s health is determined by the behavior of cells such as fibroblasts, and how chronic inflammation and the Cell Danger Response (CDR) can lead to fibrosis, creating a “cellular prison” that impairs function and perpetuates disease. The intimate relationship between the fascial/ECM environment and the immune system was highlighted, explaining how immune dysregulation and a loss of tolerance can drive chronic inflammatory and autoimmune conditions. Furthermore, we identified hyperinsulinemia as a key, often hidden, metabolic driver of this systemic inflammation. Finally, we translated this complex physiology into a practical intervention framework, discussing the nuanced application of heat and cold therapies and introducing advanced modalities such as photobiomodulation and peptides as targeted tools to restore cellular function, modulate the immune response, and promote tissue remodeling.

Conclusion

The future of medicine lies in moving beyond siloed symptom-based treatment and embracing a holistic understanding of the body’s interconnected systems. The fascial network, the immune system, and our metabolic state are not separate entities; they are in constant, dynamic conversation. Health and vitality are emergent properties of a well-functioning, resilient biological system, while chronic disease results from a system stuck in a vicious cycle of dysfunction. By understanding the underlying physiology—from the densification of the ECM to the subtleties of immune cell signaling and the devastating impact of metabolic dysregulation—we can shift our focus from merely managing disease to actively cultivating health. The ultimate therapeutic strategy addresses the root causes: it cleans up the cellular environment, restores proper signaling, provides the necessary resources for repair, and empowers the body’s innate intelligence to heal itself. This evidence-based, integrative approach is the most powerful and promising path toward extending not just our lifespan, but our healthspan.

Key Insights

  • Aging is Modifiable: View aging not as a fixed timeline but as a collection of biological processes (the “Hallmarks of Aging”) that can be influenced by lifestyle, environment, and targeted interventions.
  • The Baseline is Everything: Proactively establishing a comprehensive biological baseline is the cornerstone of preventive and personalized medicine, enabling early detection of physiological deviations.
  • Fascia is an Intelligent System: Your fascial network is a primary sensory and communication organ, not just structural “stuff.” Its health is paramount for overall well-being, movement, and cellular communication.
  • The ECM Dictates Cellular Health: The state of the Extracellular Matrix—whether it is hydrated and fluid or dense and fibrotic—directly controls the function, survival, and behavior of every cell in your body.
  • The Cell Danger Response (CDR) is a Vicious Cycle: A chronically activated CDR leads to a self-perpetuating cycle of inflammation and fibrosis, which is a root cause of many chronic pain and disease states.
  • Measure Fasting Insulin: “Normal” blood sugar can mask dangerous hyperinsulinemia, a potent driver of chronic inflammation and metabolic disease. Measuring fasting insulin is a critical, non-negotiable health metric.
  • Interventions Must Be Strategic: Therapies like heat, cold, PBM, and peptides are powerful but must be applied with a nuanced understanding of their physiological effects and the specific stage of tissue healing to be effective. The goal is to break the cycle of dysfunction and restore the body’s innate healing capacity.

References & Keywords

Keywords:

Longevity, Healthspan, Fascia, Fascial System, Extracellular Matrix (ECM), Cell Danger Response (CDR), Inflammation, Inflammaging, Cellular Senescence, Fibroblasts, Collagen, Myofascial Meridians, Immune System, Macrophages, T-cells, Immune Tolerance, Autoimmunity, Metabolic Health, Insulin Resistance, Hyperinsulinemia, Cryotherapy, Thermotherapy, Photobiomodulation (PBM), Red Light Therapy, Peptides, BPC-157, Personalized Medicine, Functional Medicine, Systems Biology, Dr. Alex Jimenez.

Selected References:

  1. López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013). The hallmarks of aging. Cell, 153(6), 1194-1217.
  2. Schleip, R., Jäger, H., & Klingler, W. (2012). What is fascia? A review of different nomenclatures. Journal of Bodywork and Movement Therapies, 16(4), 496-502.
  3. Naviaux, R. K. (2014). Metabolic features of the cell danger response. Mitochondrion, 16, 7-17.
  4. Myers, T. W. (2014). Anatomy Trains: Myofascial Meridians for Manual and Movement Therapists. 3rd ed. Churchill Livingstone.
  5. Franceschi, C., & Campisi, J. (2014). Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. The Journal of Gerontology: Series A, 69(Suppl_1), S4-S9.
  6. Crofts, C. A., Zinn, C., & Wheldon, M. (2015). The case for a low-carbohydrate diet in the management of type 2 diabetes. Expert Review of Clinical Pharmacology, 8(3), 263-265. [Note: Thematic reference for hyperinsulinemia concept].
  7. Hamblin, M. R. (2017). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics, 4(3), 337-361.
  8. Seiwerth, S., Sikiric, P., et al. (2018). BPC 157 and standard angiogenic growth factors. Synergistic effects of BPC 157 and VEGF. Current Pharmaceutical Design, 24(18), 1972-1989.
  9. Bordoni, B., & Mahabadi, N. (2021). Fascia, Function, and Medical Applications. In StatPearls. StatPearls Publishing.
  10. Langevin, H. M., & Sherman, K. J. (2007). Pathophysiological model for chronic low back pain integrating connective tissue and nervous system mechanisms. Medical Hypotheses, 68(1), 74-80.